LAVA Medtech Acquisition Corp. (LVAC)
Stock analysis · NASDAQ · Financial Services · Shell Companies
LAVA Medtech Acquisition Corp. (LVAC) is a publicly traded company in the Financial Services sector. Latest price: $10.43. Market cap $149.93M. Trailing PE 33.65. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About LAVA Medtech Acquisition Corp.
LAVA Medtech Acquisition Corp. (LVAC) currently lacks significant standalone operations. Its primary objective is to secure businesses or assets through various strategic transactions, including mergers, capital stock exchanges, asset acquisitions, stock purchases, or corporate reorganizations. The firm's strategic focus is directed towards opportunities within the healthcare and allied industries. Established in 2021, the company is based in Waltham, Massachusetts, and operates as a subsidiary of LAVA Medtech Sponsor LP.
Valuation
| P/E (TTM) | 33.65× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | 1.29× |
| P/FCF (TTM) | -227.57× |
| EV / EBITDA | -95.31× |
| EV / Sales | 0.00× |
| Earnings Yield | 3.00% |
| Free Cash Flow Yield | -0.44% |
Fundamentals
| Enterprise Value | $148.77M |
|---|---|
| Net Income (TTM) | $4.50M |
| Free Cash Flow (TTM) | -$658.82K |
| Net Debt | -$1.16M |
| Working Capital | -$3.39M |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 3.96% |
| Return on Invested Capital | -1.26% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap